Literature DB >> 16330319

Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling.

Brendan F Boyce1, Lianping Xing, Di Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330319      PMCID： PMC2647984          DOI： 10.1016/j.cmet.2005.11.011

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


× No keyword cloud information.
  7 in total

Review 1.  New aspects of Wnt signaling pathways in higher vertebrates.

Authors:  J Huelsken; W Birchmeier
Journal:  Curr Opin Genet Dev       Date:  2001-10       Impact factor: 5.578

2.  Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells.

Authors:  Amanda Jackson; Béatrice Vayssière; Teresa Garcia; William Newell; Roland Baron; Sergio Roman-Roman; Georges Rawadi
Journal:  Bone       Date:  2005-04       Impact factor: 4.398

3.  Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.

Authors:  Theo P Hill; Daniela Später; Makoto M Taketo; Walter Birchmeier; Christine Hartmann
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

4.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

5.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

6.  Essential role of beta-catenin in postnatal bone acquisition.

Authors:  Sheri L Holmen; Cassandra R Zylstra; Aditi Mukherjee; Robert E Sigler; Marie-Claude Faugere; Mary L Bouxsein; Lianfu Deng; Thomas L Clemens; Bart O Williams
Journal:  J Biol Chem       Date:  2005-03-31       Impact factor: 5.157

7.  EBF2 regulates osteoblast-dependent differentiation of osteoclasts.

Authors:  Matthias Kieslinger; Stephanie Folberth; Gergana Dobreva; Tatjana Dorn; Laura Croci; Reinhold Erben; G Giacomo Consalez; Rudolf Grosschedl
Journal:  Dev Cell       Date:  2005-12       Impact factor: 12.270
  7 in total
  17 in total

Review 1.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

2.  HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression.

Authors:  Jin Shao; Yan Zhang; Tieyi Yang; Jin Qi; Lianfang Zhang; Lianfu Deng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-04-10       Impact factor: 2.416

3.  GATA4 and estrogen receptor alpha bind at SNPs rs9921222 and rs10794639 to regulate AXIN1 expression in osteoblasts.

Authors:  Sarocha Suthon; Rachel S Perkins; Jianjian Lin; John R Crockarell; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Hum Genet       Date:  2022-06-09       Impact factor: 4.132

Review 4.  Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation.

Authors:  Albert S Kim; Christian M Girgis; Michelle M McDonald
Journal:  Curr Osteoporos Rep       Date:  2022-10-06       Impact factor: 5.163

5.  The RANKL/RANK/OPG pathway.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

6.  Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.

Authors:  Wei Yao; Zhiqiang Cheng; Mohammad Shahnazari; Wewei Dai; Mark L Johnson; Nancy E Lane
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

7.  TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis.

Authors:  Jinbo Li; Akram Ayoub; Yan Xiu; Xiaoxiang Yin; James O Sanders; Addisu Mesfin; Lianping Xing; Zhenqiang Yao; Brendan F Boyce
Journal:  Nat Commun       Date:  2019-06-26       Impact factor: 14.919

Review 8.  Biology of RANK, RANKL, and osteoprotegerin.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy.

Authors:  Matthew R Steensma; Wakenda K Tyler; Allison G Shaber; Steven R Goldring; F Patrick Ross; Bart O Williams; John H Healey; P Edward Purdue
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Expression and Presence of OPG and RANKL mRNA and Protein in Human Periodontal Ligament with Orthodontic Force.

Authors:  Liliana Otero; Dabeiba Adriana García; Liseth Wilches-Buitrago
Journal:  Gene Regul Syst Bio       Date:  2016-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.